Cargando…

Maximum Somatic Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden Predicts the Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Recent studies exhibited the unstable prediction ability of blood-based tumor mutational burden (bTMB) when predicting the response of immune checkpoint inhibitors (ICIs) therapy in patients with non-small cell lung cancer (NSCLC). Circulating tumor DNA (ctDNA) abundance, usually rep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Yiting, Zhu, Yixiang, Zhuo, Minglei, Chen, Xiaomin, Xie, Yinpeng, Duan, Jianchun, Bai, Hua, Hao, Shiguang, Yu, Zicheng, Yi, Yuting, Guan, Yanfang, Yuan, Jie, Xia, Xuefeng, Yi, Xin, Wang, Jie, Wang, Zhijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688065/ https://www.ncbi.nlm.nih.gov/pubmed/36428744 http://dx.doi.org/10.3390/cancers14225649

Ejemplares similares

Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer
por: Yang, Xue, et al.
Publicado: (2016)

Multi-omics indicators of long-term survival benefits after immune checkpoint inhibitor therapy
por: Zhao, Jie, et al.
Publicado: (2023)

Correlation among genetic variations of c-MET in Chinese patients with non-small cell lung cancer
por: Duan, Jianchun, et al.
Publicado: (2017)

Epidermal growth factor receptor variant III mutation in Chinese patients with squamous cell cancer of the lung
por: Duan, Jianchun, et al.
Publicado: (2015)

Adjustments for obtaining maximum intensity from the CPS
por: Reich, K H
Publicado: (1961)

Adjustments for obtaining maximum intensity from the CPS
por: Reich, KH
Publicado: (1961)

Identification and validation of tissue or ctDNA PTPRD phosphatase domain deleterious mutations as prognostic and predictive biomarkers for immune checkpoint inhibitors in non-squamous NSCLC
por: Sun, Yiting, et al.
Publicado: (2021)

Efficacy and safety of weekly intravenous nanoparticle albumin‐bound paclitaxel for non‐small cell lung cancer patients who have failed at least two prior systemic treatments
por: Duan, Jianchun, et al.
Publicado: (2017)

Allelic imbalance in CALR somatic mutagenesis
por: Harutyunyan, A S, et al.
Publicado: (2015)

Efficacy and safety of nab-paclitaxel or combined nab-paclitaxel and immune checkpoint inhibitors in relapsed small-cell lung cancer
por: Wan, Rui, et al.
Publicado: (2023)

Genomic Selection with Allele Dosage in Panicum maximum Jacq.
por: de C. Lara, Letícia A., et al.
Publicado: (2019)

Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer
por: Bai, Hua, et al.
Publicado: (2013)

PAPPA2 mutation as a novel indicator stratifying beneficiaries of immune checkpoint inhibitors in skin cutaneous melanoma and non‐small cell lung cancer
por: Dong, Yiting, et al.
Publicado: (2022)

Adjusting the energy of interfacial states in organic photovoltaics for maximum efficiency
por: Gasparini, Nicola, et al.
Publicado: (2021)

Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation
por: Wang, Shuhang, et al.
Publicado: (2015)

Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC
por: Wang, Zhijie, et al.
Publicado: (2014)

Systematic pan-cancer analysis of somatic allele frequency
por: Spurr, Liam, et al.
Publicado: (2018)

Allelic imbalance of somatic mutations in cancer genomes and transcriptomes
por: Rhee, Je-Keun, et al.
Publicado: (2017)

Constrained Adjusted Maximum a Posteriori Estimation of Bayesian Network Parameters
por: Di, Ruohai, et al.
Publicado: (2021)

DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer
por: Zhu, Jian, et al.
Publicado: (2012)

Retrospective analysis of the effectiveness and tolerability of nab‐paclitaxel in Chinese elderly patients with advanced non‐small‐cell lung carcinoma
por: Wang, Shuhang, et al.
Publicado: (2020)

Blockade of STAT3/IL-4 overcomes EGFR T790M-cis-L792F-induced resistance to osimertinib via suppressing M2 macrophages polarization
por: Sun, Yiting, et al.
Publicado: (2022)

Checkpoint kinase 1 negatively regulates somatic hypermutation
por: Frankenberger, Samantha, et al.
Publicado: (2014)

Overexpressed somatic alleles are enriched in functional elements in Breast Cancer
por: Restrepo, Paula, et al.
Publicado: (2017)

Adjustment Effects of Maximum Intensity Tolerance During Whole-Body Electromyostimulation Training
por: Berger, Joshua, et al.
Publicado: (2019)

Establishment of prognostic nomograms for predicting the progression free survival of EGFR‐sensitizing mutation, advanced lung cancer patients treated with EGFR‐TKIs
por: Du, Xinyang, et al.
Publicado: (2022)

Reporting quality of randomized, controlled trials evaluating immunotherapy in lung cancer
por: Du, Jun, et al.
Publicado: (2021)

A Maximum-Likelihood Method to Correct for Allelic Dropout in Microsatellite Data with No Replicate Genotypes
por: Wang, Chaolong, et al.
Publicado: (2012)

Evaluation of Allele-Specific Somatic Changes of Genome-Wide Association Study Susceptibility Alleles in Human Colorectal Cancers
por: Gerber, Madelyn M., et al.
Publicado: (2012)

Methodology of mixed load customized bus lines and adjustment based on time windows
por: Li, ZhiJie, et al.
Publicado: (2018)

Allelic Selection of Amplicons in Glioblastoma Revealed by Combining Somatic and Germline Analysis
por: LaFramboise, Thomas, et al.
Publicado: (2010)

Continuously Adjustable, Molecular-Sieving “Gate” on 5A Zeolite for Distinguishing Small Organic Molecules by Size
por: Song, Zhuonan, et al.
Publicado: (2015)

Catalytic Enantioselective Aryl Transfer to Aldehydes Using Chiral 2,2’-Bispyrrolidine-Based Salan Ligands
por: Jia, Xuefeng, et al.
Publicado: (2011)

Deep neural network classification based on somatic mutations potentially predicts clinical benefit of immune checkpoint blockade in lung adenocarcinoma
por: Peng, Jie, et al.
Publicado: (2020)

Clinical implications of somatic allele expansion in female FMR1 premutation carriers
por: Aishworiya, Ramkumar, et al.
Publicado: (2023)

Deep learning identifies a T-cell exhaustion-dependent transcriptional signature for predicting clinical outcomes and response to immune checkpoint blockade
por: Zhang, Zicheng, et al.
Publicado: (2023)

Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies
por: Yan, Yu-Chuan, et al.
Publicado: (2022)

Changes in neck pain and somatic symptoms before and after the adjustment of the pillow height
por: Yamada, Shuori, et al.
Publicado: (2023)

Releation between marital adjustment and somatic symptoms on parents of children with Spina Bifida
por: Ulual, P., et al.
Publicado: (2023)

Maximum Somatic Allele Frequency in Combination With Blood-Based Tumor Mutational Burden to Predict the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer: A Pooled Analysis of the Randomized POPLAR and OAK Studies
por: Chen, Yu-tong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8jqcu7qhj5lmcudrp2caqod93k